Follow-up questionnaire completion rate was 29 from 42 posted. The clinic demonstrated little change in the parameters measured over the three months. Post-intervention, participants were more willing to speak to the pharmacist regarding a greater variety of topics related to their condition. All of the participants
rated their general BMS-354825 research buy impression of the service as good or very good and all would be happy to recommend the service to others with diabetes. Sixteen participants (59%) stated that it would make them more likely to consult their pharmacist in the future. Pharmacists enjoyed providing the service as it allowed them to interact more formally, and for longer, with patients. Pharmacists highlighted that questionnaire burden may be something that needs addressing in further studies. This research has demonstrated that a community pharmacy drop-in clinic is feasible and likely to be acceptable to both patients and pharmacists. Medical practice referral was via a letter and achieved an almost 10% response rate. In order to increase this, direct
selleckchem referral by the GP or practice nurse should be investigated. The presence of a second pharmacist to allow the consultation to last as long as necessary will need to be factored into the design of a larger study. Alternative methods of data collection to questionnaires may need to be investigated to reduce participant burden. Methods of collecting follow-up clinical data will also stiripentol need to be examined. The research team will proceed with a full pilot-study based on the results from the feasibility testing. 1. Twigg M, Desborough J, Bhattacharya D, Wright D. An audit of prescribing for type 2 diabetes in primary care: optimising the role of the community pharmacist in the primary healthcare team. Primary Health
Care Res Dev 2012;FirstView:1–5. 2. Twigg M, Poland F, Bhattacharya D, Desborough J, Wright D. The current and future roles of community pharmacists: Views and experiences of patients with type 2 diabetes. Res. Soc. Adm. Pharm.; In Press. Jim Chai1, Claire Anderson2, Kok Thong Wong1, Zanariah Hussein3 1University of Nottingham Malaysia Campus, Selangor, Malaysia, 2University of Nottingham, Nottingham, UK, 3Putrajaya Hospital, Putrajaya, Malaysia Insulin therapy can significantly reduce morbidity and mortality when introduced at an early stage. Only 7.2% of type 2 diabetes patients in Malaysia use insulin1, 50.7% of patients are not willing to accept insulin therapy2. The major fear comes from a lack of knowledge of insulin. Early diabetes education may make people more aware of their health condition and the function of insulin, which may better prepare them mentally for insulin therapy. Type 2 diabetes mellitus (T2DM) is a progressive disease, due to its nature, insulin therapy can significantly reduce morbidity and mortality if introduced to suitable patients at an early stage, or aggressively enough to achieve their glycaemic control.